Identification and characterization of a novel mutation in von Willebrand factor causing type 2B von Willebrand's disease

Type 2B von Willebrand's disease (VWD) is a variant in which the structurally abnormal von Willebrand factor (VWF) has an increased affinity for the platelet glycoprotein Ib–IX–V complex. Spontaneous binding of type 2B VWF to platelets and their subsequent clearance from the plasma appear to ac...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:British journal of haematology 1999-05, Vol.105 (2), p.538-541
Hauptverfasser: Facey, David A., Favaloro, Emmanuel J., Koutts, Jerry, Berndt, Michael C., Hertzberg, Mark S.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 541
container_issue 2
container_start_page 538
container_title British journal of haematology
container_volume 105
creator Facey, David A.
Favaloro, Emmanuel J.
Koutts, Jerry
Berndt, Michael C.
Hertzberg, Mark S.
description Type 2B von Willebrand's disease (VWD) is a variant in which the structurally abnormal von Willebrand factor (VWF) has an increased affinity for the platelet glycoprotein Ib–IX–V complex. Spontaneous binding of type 2B VWF to platelets and their subsequent clearance from the plasma appear to account for the characteristic phenotype of type 2B VWD. Several type 2B mutations have been described and shown to be grouped along the amino edge of the beta sheet of the VWF A1 domain. In this report we describe a novel missense mutation, Arg543Leu, in the VWF A1 domain in three members of a family with type 2B VWD. We have expressed and characterized the corresponding recombinant mutant VWF in transiently transfected COS‐7 cells. Relative to wild‐type VWF, recombinant Arg543Leu VWF showed a similar multimer composition but exhibited binding to fixed platelets both in the presence and absence of ristocetin, confirming the ability of this mutation to permit spontaneous interaction of VWF with platelets. These studies are consistent with a recently proposed model in which the VWF‐A1 domain exists in either ‘on’ or ‘off’ states, with type 2B mutations switching VWF to an ‘on’ state to facilitate GPIb binding.
doi_str_mv 10.1111/j.1365-2141.1999.01358.x
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69774982</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>41823800</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3188-a41fe15f9cb5f771d2290aa72f50a39d64a9154e254ccfc8c848c12c80fffc8e3</originalsourceid><addsrcrecordid>eNqNkUtv1DAURq0K1E5L_0JlIURXCb5-jO0FC1rRB6rEBsTS8jg2eJRJBjspHX49TjMqqCu8uX6c79ryQQgDqaGMd-sa2FJUFDjUoLWuCTCh6ocDtHg6eIEWhBBZAeHqCB3nvCaFIgIO0REQyhhnfIF2t43vhhiis0PsO2y7BrsfNlk3-BR_z5t9wBZ3_b1v8WYc5r3Y4ftSvsW29as0xULJ9Ak7O-bYfcfDbusxvXhGnWfcxOxt9q_Qy2Db7E_39QR9vfr45fKmuvt8fXv54a5yDJSqLIfgQQTtViJICQ2lmlgraRDEMt0sudUguKeCOxeccoorB9QpEkJZenaC3s59t6n_Ofo8mE3Mzret7Xw_ZrPUUnKtaAFfPwPX_Zi68jYDWglNKCwLpGbIpT7n5IPZprixaWeAmMmNWZtJgZkUmMmNeXRjHkr0bN9_XG18809wllGAN3vAZmfbUP7LxfyXk1JTKQv2fsZ-xdbv_vt-c_HpZpqxPzB3quw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>198590216</pqid></control><display><type>article</type><title>Identification and characterization of a novel mutation in von Willebrand factor causing type 2B von Willebrand's disease</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Wiley Free Content</source><creator>Facey, David A. ; Favaloro, Emmanuel J. ; Koutts, Jerry ; Berndt, Michael C. ; Hertzberg, Mark S.</creator><creatorcontrib>Facey, David A. ; Favaloro, Emmanuel J. ; Koutts, Jerry ; Berndt, Michael C. ; Hertzberg, Mark S.</creatorcontrib><description>Type 2B von Willebrand's disease (VWD) is a variant in which the structurally abnormal von Willebrand factor (VWF) has an increased affinity for the platelet glycoprotein Ib–IX–V complex. Spontaneous binding of type 2B VWF to platelets and their subsequent clearance from the plasma appear to account for the characteristic phenotype of type 2B VWD. Several type 2B mutations have been described and shown to be grouped along the amino edge of the beta sheet of the VWF A1 domain. In this report we describe a novel missense mutation, Arg543Leu, in the VWF A1 domain in three members of a family with type 2B VWD. We have expressed and characterized the corresponding recombinant mutant VWF in transiently transfected COS‐7 cells. Relative to wild‐type VWF, recombinant Arg543Leu VWF showed a similar multimer composition but exhibited binding to fixed platelets both in the presence and absence of ristocetin, confirming the ability of this mutation to permit spontaneous interaction of VWF with platelets. These studies are consistent with a recently proposed model in which the VWF‐A1 domain exists in either ‘on’ or ‘off’ states, with type 2B mutations switching VWF to an ‘on’ state to facilitate GPIb binding.</description><identifier>ISSN: 0007-1048</identifier><identifier>EISSN: 1365-2141</identifier><identifier>DOI: 10.1111/j.1365-2141.1999.01358.x</identifier><identifier>PMID: 10233434</identifier><identifier>CODEN: BJHEAL</identifier><language>eng</language><publisher>Oxford, U.K. and Cambridge, USA: Blackwell Science Ltd</publisher><subject>Biological and medical sciences ; Female ; Hematologic and hematopoietic diseases ; Hematology ; Hemostasis ; Heterozygote ; Humans ; Medical sciences ; Middle Aged ; mutation ; Mutation, Missense - genetics ; Platelet diseases and coagulopathies ; recombinant ; von Willebrand Diseases - blood ; von Willebrand Diseases - genetics ; von Willebrand Factor - genetics ; VWD type 2B ; VWF</subject><ispartof>British journal of haematology, 1999-05, Vol.105 (2), p.538-541</ispartof><rights>1999 INIST-CNRS</rights><rights>Copyright Blackwell Scientific Publications Ltd. May 1999</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3188-a41fe15f9cb5f771d2290aa72f50a39d64a9154e254ccfc8c848c12c80fffc8e3</citedby><cites>FETCH-LOGICAL-c3188-a41fe15f9cb5f771d2290aa72f50a39d64a9154e254ccfc8c848c12c80fffc8e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1365-2141.1999.01358.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1365-2141.1999.01358.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,777,781,1412,1428,27905,27906,45555,45556,46390,46814</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=1779277$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10233434$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Facey, David A.</creatorcontrib><creatorcontrib>Favaloro, Emmanuel J.</creatorcontrib><creatorcontrib>Koutts, Jerry</creatorcontrib><creatorcontrib>Berndt, Michael C.</creatorcontrib><creatorcontrib>Hertzberg, Mark S.</creatorcontrib><title>Identification and characterization of a novel mutation in von Willebrand factor causing type 2B von Willebrand's disease</title><title>British journal of haematology</title><addtitle>Br J Haematol</addtitle><description>Type 2B von Willebrand's disease (VWD) is a variant in which the structurally abnormal von Willebrand factor (VWF) has an increased affinity for the platelet glycoprotein Ib–IX–V complex. Spontaneous binding of type 2B VWF to platelets and their subsequent clearance from the plasma appear to account for the characteristic phenotype of type 2B VWD. Several type 2B mutations have been described and shown to be grouped along the amino edge of the beta sheet of the VWF A1 domain. In this report we describe a novel missense mutation, Arg543Leu, in the VWF A1 domain in three members of a family with type 2B VWD. We have expressed and characterized the corresponding recombinant mutant VWF in transiently transfected COS‐7 cells. Relative to wild‐type VWF, recombinant Arg543Leu VWF showed a similar multimer composition but exhibited binding to fixed platelets both in the presence and absence of ristocetin, confirming the ability of this mutation to permit spontaneous interaction of VWF with platelets. These studies are consistent with a recently proposed model in which the VWF‐A1 domain exists in either ‘on’ or ‘off’ states, with type 2B mutations switching VWF to an ‘on’ state to facilitate GPIb binding.</description><subject>Biological and medical sciences</subject><subject>Female</subject><subject>Hematologic and hematopoietic diseases</subject><subject>Hematology</subject><subject>Hemostasis</subject><subject>Heterozygote</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>mutation</subject><subject>Mutation, Missense - genetics</subject><subject>Platelet diseases and coagulopathies</subject><subject>recombinant</subject><subject>von Willebrand Diseases - blood</subject><subject>von Willebrand Diseases - genetics</subject><subject>von Willebrand Factor - genetics</subject><subject>VWD type 2B</subject><subject>VWF</subject><issn>0007-1048</issn><issn>1365-2141</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkUtv1DAURq0K1E5L_0JlIURXCb5-jO0FC1rRB6rEBsTS8jg2eJRJBjspHX49TjMqqCu8uX6c79ryQQgDqaGMd-sa2FJUFDjUoLWuCTCh6ocDtHg6eIEWhBBZAeHqCB3nvCaFIgIO0REQyhhnfIF2t43vhhiis0PsO2y7BrsfNlk3-BR_z5t9wBZ3_b1v8WYc5r3Y4ftSvsW29as0xULJ9Ak7O-bYfcfDbusxvXhGnWfcxOxt9q_Qy2Db7E_39QR9vfr45fKmuvt8fXv54a5yDJSqLIfgQQTtViJICQ2lmlgraRDEMt0sudUguKeCOxeccoorB9QpEkJZenaC3s59t6n_Ofo8mE3Mzret7Xw_ZrPUUnKtaAFfPwPX_Zi68jYDWglNKCwLpGbIpT7n5IPZprixaWeAmMmNWZtJgZkUmMmNeXRjHkr0bN9_XG18809wllGAN3vAZmfbUP7LxfyXk1JTKQv2fsZ-xdbv_vt-c_HpZpqxPzB3quw</recordid><startdate>199905</startdate><enddate>199905</enddate><creator>Facey, David A.</creator><creator>Favaloro, Emmanuel J.</creator><creator>Koutts, Jerry</creator><creator>Berndt, Michael C.</creator><creator>Hertzberg, Mark S.</creator><general>Blackwell Science Ltd</general><general>Blackwell</general><general>Blackwell Publishing Ltd</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>199905</creationdate><title>Identification and characterization of a novel mutation in von Willebrand factor causing type 2B von Willebrand's disease</title><author>Facey, David A. ; Favaloro, Emmanuel J. ; Koutts, Jerry ; Berndt, Michael C. ; Hertzberg, Mark S.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3188-a41fe15f9cb5f771d2290aa72f50a39d64a9154e254ccfc8c848c12c80fffc8e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Biological and medical sciences</topic><topic>Female</topic><topic>Hematologic and hematopoietic diseases</topic><topic>Hematology</topic><topic>Hemostasis</topic><topic>Heterozygote</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>mutation</topic><topic>Mutation, Missense - genetics</topic><topic>Platelet diseases and coagulopathies</topic><topic>recombinant</topic><topic>von Willebrand Diseases - blood</topic><topic>von Willebrand Diseases - genetics</topic><topic>von Willebrand Factor - genetics</topic><topic>VWD type 2B</topic><topic>VWF</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Facey, David A.</creatorcontrib><creatorcontrib>Favaloro, Emmanuel J.</creatorcontrib><creatorcontrib>Koutts, Jerry</creatorcontrib><creatorcontrib>Berndt, Michael C.</creatorcontrib><creatorcontrib>Hertzberg, Mark S.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>British journal of haematology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Facey, David A.</au><au>Favaloro, Emmanuel J.</au><au>Koutts, Jerry</au><au>Berndt, Michael C.</au><au>Hertzberg, Mark S.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Identification and characterization of a novel mutation in von Willebrand factor causing type 2B von Willebrand's disease</atitle><jtitle>British journal of haematology</jtitle><addtitle>Br J Haematol</addtitle><date>1999-05</date><risdate>1999</risdate><volume>105</volume><issue>2</issue><spage>538</spage><epage>541</epage><pages>538-541</pages><issn>0007-1048</issn><eissn>1365-2141</eissn><coden>BJHEAL</coden><abstract>Type 2B von Willebrand's disease (VWD) is a variant in which the structurally abnormal von Willebrand factor (VWF) has an increased affinity for the platelet glycoprotein Ib–IX–V complex. Spontaneous binding of type 2B VWF to platelets and their subsequent clearance from the plasma appear to account for the characteristic phenotype of type 2B VWD. Several type 2B mutations have been described and shown to be grouped along the amino edge of the beta sheet of the VWF A1 domain. In this report we describe a novel missense mutation, Arg543Leu, in the VWF A1 domain in three members of a family with type 2B VWD. We have expressed and characterized the corresponding recombinant mutant VWF in transiently transfected COS‐7 cells. Relative to wild‐type VWF, recombinant Arg543Leu VWF showed a similar multimer composition but exhibited binding to fixed platelets both in the presence and absence of ristocetin, confirming the ability of this mutation to permit spontaneous interaction of VWF with platelets. These studies are consistent with a recently proposed model in which the VWF‐A1 domain exists in either ‘on’ or ‘off’ states, with type 2B mutations switching VWF to an ‘on’ state to facilitate GPIb binding.</abstract><cop>Oxford, U.K. and Cambridge, USA</cop><pub>Blackwell Science Ltd</pub><pmid>10233434</pmid><doi>10.1111/j.1365-2141.1999.01358.x</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0007-1048
ispartof British journal of haematology, 1999-05, Vol.105 (2), p.538-541
issn 0007-1048
1365-2141
language eng
recordid cdi_proquest_miscellaneous_69774982
source MEDLINE; Wiley Online Library Journals Frontfile Complete; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Wiley Free Content
subjects Biological and medical sciences
Female
Hematologic and hematopoietic diseases
Hematology
Hemostasis
Heterozygote
Humans
Medical sciences
Middle Aged
mutation
Mutation, Missense - genetics
Platelet diseases and coagulopathies
recombinant
von Willebrand Diseases - blood
von Willebrand Diseases - genetics
von Willebrand Factor - genetics
VWD type 2B
VWF
title Identification and characterization of a novel mutation in von Willebrand factor causing type 2B von Willebrand's disease
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T19%3A26%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Identification%20and%20characterization%20of%20a%20novel%20mutation%20in%20von%20Willebrand%20factor%20causing%20type%202B%20von%20Willebrand's%20disease&rft.jtitle=British%20journal%20of%20haematology&rft.au=Facey,%20David%20A.&rft.date=1999-05&rft.volume=105&rft.issue=2&rft.spage=538&rft.epage=541&rft.pages=538-541&rft.issn=0007-1048&rft.eissn=1365-2141&rft.coden=BJHEAL&rft_id=info:doi/10.1111/j.1365-2141.1999.01358.x&rft_dat=%3Cproquest_cross%3E41823800%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=198590216&rft_id=info:pmid/10233434&rfr_iscdi=true